BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use ...
Set the bar and then beat it; that's what Vertex Pharmaceuticals has just done with a next-gen cystic fibrosis (CF) treatment. The investigational treatment is a once-daily triple CFTR modulator ...
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that data on TRIKAFTA ® (elexacaftor/tezacaftor/ivacaftor and ivacaftor ...
COLORADO (KCNC) — Some Coloradans are sounding an alarm after learning a state board is considering capping the price of a life-saving drug. They’re worried the move could cause the manufacturer to ...
Cystic fibrosis miracle drug Trikafta, helps 90% of people, the other 10% are still waiting for their aid. The small box full of promises arrived at Jessica Anderson’s home on her 31st birthday. A ...
Cystic fibrosis (CF) patients and their families in England can rest a little easier this week, thanks to an extended long-term reimbursement deal inked by Vertex Pharmaceuticals and the country’s ...
History may repeat for Vertex Pharmaceuticals in the U.K., where a new decision by the country’s cost-effectiveness gatekeeper threatens to spark another dispute over the cost of lifesaving cystic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback